SECURITIES AND EXCHANGE COMMISSION
Washington, D.C. 20549
FORM 8-K
CURRENT REPORT
Pursuant to Section 13 or 15(d) of the Securities Exchange Act of 1934
Date of Report (Date of earliest event reported) December 20, 1996
OSTEOTECH, INC.
(Exact name of registrant as specified in its charter)
Delaware 0-19278 13-3357370
(State or other jurisdiction (Commission (IRS Employer
of incorporation) File Number) Identification)
51 James Way, Eatontown, New Jersey 07724
- ----------------------------------------------------------------
(Address of principal executive offices) (Zip Code)
Registrant's telephone number, including area code (908) 542-2800
(Former name or former address, if changed since last report)
<PAGE>
Item 5. Other Events
On December 20, 1996, the Company announced that it had signed
a new ten year agreement, effective January 1, 1997, for Osteotech to continue
to be the exclusive processor of musculoskeletal tissue procured and distributed
by American Red Cross Tissue Services. As part of the agreement, Osteotech will
provide additional support to American Red Cross Tissue Services to include the
continued marketing and surgeon education for Osteotech's proprietary Grafton
DBM allograft tissue technology.
<PAGE>
SIGNATURES
Pursuant to the requirements of the Securities Exchange Act of
1934, the Registrant has duly caused this report to be signed on its behalf by
the undersigned hereunto duly authorized.
Dated: December 30, 1996
OSTEOTECH, INC.
(Registrant)
By: /S/ MICHAEL J. JEFFRIES
---------------------------
Michael J. Jeffries
Executive Vice President,
Chief Financial Officer and
Secretary
